EFFECT OF CONTINUED TREATMENT WITH PIRFENIDONE FOLLOWING A >= 10% RELATIVE DECLINE IN PERCENT PREDICTED FORCED VITAL CAPACITY (%FVC) IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)

Wells A. U.; Albera C.; Costabel U.; Glaspole I.; Glassberg M. K.; Lancaster L.; Lederer D. J.; Pereira C. A.; Swigris J. J.; Day B-M; Chou W.; Nathan S. D.

首页> 外文期刊>Thorax: The Journal of the British Thoracic Society >EFFECT OF CONTINUED TREATMENT WITH PIRFENIDONE FOLLOWING A >= 10% RELATIVE DECLINE IN PERCENT PREDICTED FORCED VITAL CAPACITY (%FVC) IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)

【24h】

EFFECT OF CONTINUED TREATMENT WITH PIRFENIDONE FOLLOWING A >= 10% RELATIVE DECLINE IN PERCENT PREDICTED FORCED VITAL CAPACITY (%FVC) IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)

机译：在患有特发性肺纤维化（IPF）的患者预期强制性肺活量（％FVC）百分比下降> = 10％的情况下连续使用吡非尼酮治疗的效果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Thorax: The Journal of the British Thoracic Society》 |2016年第3期|共1页
作者
Wells A. U.; Albera C.; Costabel U.; Glaspole I.; Glassberg M. K.; Lancaster L.; Lederer D. J.; Pereira C. A.; Swigris J. J.; Day B-M; Chou W.; Nathan S. D.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. EFFECT OF CONTINUED TREATMENT WITH PIRFENIDONE FOLLOWING A >= 10% RELATIVE DECLINE IN PERCENT PREDICTED FORCED VITAL CAPACITY (%FVC) IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) [J] . Wells A. U., Albera C., Costabel U., Thorax: The Journal of the British Thoracic Society . 2016,第Suppla3期

机译：在患有特发性肺纤维化（IPF）的患者预期强制性肺活量（％FVC）百分比下降> = 10％的情况下连续使用吡非尼酮治疗的效果
2. EFFECT OF PIRFENIDONE ON ALL-CAUSE MORTALITY (ACM) AND FORCED VITAL CAPACITY (FVC) IN IDIOPATHIC PULMONARY FIBROSIS (IPF) PATIENTS WITH LOW FVC AND/OR LOW DLCO: ANALYSIS OF POOLED DATA FROM ASCEND AND CAPACITY [J] . Nathan S. D., Costabel U., Albera C., Thorax: The Journal of the British Thoracic Society . 2017,第Suppla3期

机译：Pirefenidone对特发性肺纤维化（IPF）低FVC和/或低DLCO患者的所有原因死亡率（ACM）和强制生命能力（FVC）的影响：从升高和容量分析汇总数据
3. Composite Physiologic Index, Percent Forced Vital Capacity and Percent Diffusing Capacity for Carbon Monoxide Could Be Predictors of Pirfenidone Tolerability in Patients with Idiopathic Pulmonary Fibrosis [J] . Konishi Satoshi, Arita Machiko, Ito Isao, Internal medicine. . 2015,第22期

机译：一氧化碳的复合生理指标，强制肺活量百分数和一氧化碳扩散能力百分数可能是吡非尼酮耐受性特发性肺纤维化患者的预测指标
4. U-radiomics for predicting survival of patients with idiopathic pulmonary fibrosis [C] . Tomoki Uemura, Chinatsu Watari, Janne J.Naeppi, Medical Imaging Conference . 2020

机译：U放射组学可预测特发性肺纤维化患者的生存
5. Original article: Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis [O] . Steven D Nathan, Carlo Albera, Williamson Z Bradford, -1

机译：原始文章：强制性肺活量的临床意义下降后继续用吡非尼酮治疗的效果：特发性肺纤维化患者三项三期试验的数据分析
6. P174 Effect of continued treatment with pirfenidone following a ≥10 relative decline in percent predicted forced vital capacity (FVC) in patients with idiopathic pulmonary fibrosis (IPF) [O] . AU Wells, C Albera, U Costabel, 2016

机译：P174持续治疗与Pirfenidone持续后≥10％相对下降的百分比预测肺纤维化患者（IPF）的百分比百分比预测的强迫致命能力（％FVC）

EFFECT OF CONTINUED TREATMENT WITH PIRFENIDONE FOLLOWING A >= 10% RELATIVE DECLINE IN PERCENT PREDICTED FORCED VITAL CAPACITY (%FVC) IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)

著录项

相似文献

相关主题

期刊订阅